dapsone has been researched along with Acute Liver Injury, Drug-Induced in 47 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "During treatment of multibacillary leprosy with the combination rifampin (RMP) 600 mg, ethionamide (ETH) 500 mg, and either dapsone (DDS) or clofazimine (CLO) 100 mg, hepatotoxicity was observed in 4." | 9.05 | Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy. ( Bourland, J; Davies, EM; Feracci, C; Grillone, S; Janssens, L; Pattyn, SR; Saylan, T, 1984) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 7.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "A 34-year-old woman with HIV infection and no other opportunistic infections presented a classic sulfone syndrome, manifested by fever, rash, hemolytic anemia, and fulminant hepatitis due to dapsone hypersensitive reaction, with a fatal outcome." | 7.69 | Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. ( Baffoe-Bonnie, H; Chalasani, P; Jurado, RL, 1994) |
| "Side-effects of leprosy treatment with dapsone are said to be uncommon, with drug allergy occurring in only one of every several hundred patients treated with dapsone." | 7.68 | Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. ( Ala, J; Hall, JJ; Reeve, PA, 1992) |
| "A 13% incidence of hepatitis was observed among 54 cases of multibacillary leprosy treated daily with the three-drug combination of dapsone, rifampin, and a thioamide (ethionamide or prothionamide)." | 7.66 | Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide. ( Cartel, JL; Grosset, JH; Guelpa-Lauras, CC; Millan, J, 1983) |
| "In patients with AIDS, oral therapy with trimethoprim-sulfamethoxazole and with trimethoprim-dapsone are equally effective for mild-to-moderate first episodes of P." | 6.67 | Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. ( Benowitz, N; Hopewell, PC; Lee, B; Leoung, G; Medina, I; Mills, J; Modin, G; Wofsy, CB, 1990) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 5.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| "During treatment of multibacillary leprosy with the combination rifampin (RMP) 600 mg, ethionamide (ETH) 500 mg, and either dapsone (DDS) or clofazimine (CLO) 100 mg, hepatotoxicity was observed in 4." | 5.05 | Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy. ( Bourland, J; Davies, EM; Feracci, C; Grillone, S; Janssens, L; Pattyn, SR; Saylan, T, 1984) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 3.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "An elderly patient with borderline tuberculoid Hansen's disease (leprosy) developed the diaminodiphenylsulphone syndrome after approximately 8 weeks of multi-drug therapy comprising dapsone and rifampicin." | 3.69 | A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: dapsone syndrome or rifampicin toxicity? ( Lau, G, 1995) |
| "A male patient who was being treated with oral prednisone for erosive mucocutaneous pemphigus lesions developed fever, jaundice, a rash, and anemia within 2 wk of starting dapsone therapy." | 3.69 | Sulfone syndrome in a patient receiving steroids for pemphigus. ( Barnard, GF; Dagher, RK; Scharf, MJ, 1994) |
| "A 34-year-old woman with HIV infection and no other opportunistic infections presented a classic sulfone syndrome, manifested by fever, rash, hemolytic anemia, and fulminant hepatitis due to dapsone hypersensitive reaction, with a fatal outcome." | 3.69 | Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. ( Baffoe-Bonnie, H; Chalasani, P; Jurado, RL, 1994) |
| "Side-effects of leprosy treatment with dapsone are said to be uncommon, with drug allergy occurring in only one of every several hundred patients treated with dapsone." | 3.68 | Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. ( Ala, J; Hall, JJ; Reeve, PA, 1992) |
| "A patient being treated with dapsone developed a hypersensitivity reaction with typical features of the "sulfone syndrome," including fever, malalse, and hepatitis." | 3.67 | Liver involvement in the sulfone syndrome. ( Cattau, EL; Johnson, DA; Kuritsky, JN; Zimmerman, HJ, 1986) |
| "Exfoliative dermatitis associated with hepatitis has been reported in leprosy patients taking dapsone in daily dosage of 200 mg daily or more previously." | 3.66 | Sulphone induced exfoliative dermatitis and hepatitis. ( Garg, BR; Lal, S, 1980) |
| "A 13% incidence of hepatitis was observed among 54 cases of multibacillary leprosy treated daily with the three-drug combination of dapsone, rifampin, and a thioamide (ethionamide or prothionamide)." | 3.66 | Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide. ( Cartel, JL; Grosset, JH; Guelpa-Lauras, CC; Millan, J, 1983) |
| "In patients with AIDS, oral therapy with trimethoprim-sulfamethoxazole and with trimethoprim-dapsone are equally effective for mild-to-moderate first episodes of P." | 2.67 | Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. ( Benowitz, N; Hopewell, PC; Lee, B; Leoung, G; Medina, I; Mills, J; Modin, G; Wofsy, CB, 1990) |
| "Drugs producing acute liver failure (ALF) are uncommon and vary geographically." | 1.48 | Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients. ( Devarbhavi, H; Ganga, D; Joseph, T; Patil, M; Reddy, VV; Singh, R, 2018) |
| "Dapsone is a sulfone-type drug used widely for different infectious, immune, and hypersensitivity disorders as an antibacterial treatment alone or in combination for leprosy and sometimes for infected skin lesions." | 1.40 | Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: a case report. ( Choi, YR; Garcia, A; Hong, G; Kang, EK; Kang, HJ; Kim, JG; Lee, JM; Lee, KB; Lee, KW; Park, JD; Suh, KS; Suh, SW; Yi, NJ; You, T, 2014) |
| " An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems." | 1.36 | Developing structure-activity relationships for the prediction of hepatotoxicity. ( Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 1.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| " Once the patient's liver function normalized, prednisone dosage was reduced by 5 mg weekly." | 1.29 | Dapsone hypersensitivity syndrome. ( Prussick, R; Shear, NH, 1996) |
| " Dosage data indicated that fatalities had taken higher doses and continued prophylaxis after onset of symptoms." | 1.28 | Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. ( Phillips-Howard, PA; West, LJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (21.28) | 18.7374 |
| 1990's | 15 (31.91) | 18.2507 |
| 2000's | 5 (10.64) | 29.6817 |
| 2010's | 15 (31.91) | 24.3611 |
| 2020's | 2 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fourches, D | 1 |
| Barnes, JC | 1 |
| Day, NC | 1 |
| Bradley, P | 1 |
| Reed, JZ | 1 |
| Tropsha, A | 1 |
| Greene, N | 1 |
| Fisk, L | 1 |
| Naven, RT | 1 |
| Note, RR | 1 |
| Patel, ML | 1 |
| Pelletier, DJ | 1 |
| Morgan, RE | 2 |
| Trauner, M | 1 |
| van Staden, CJ | 2 |
| Lee, PH | 1 |
| Ramachandran, B | 1 |
| Eschenberg, M | 1 |
| Afshari, CA | 2 |
| Qualls, CW | 1 |
| Lightfoot-Dunn, R | 1 |
| Hamadeh, HK | 2 |
| Ekins, S | 1 |
| Williams, AJ | 1 |
| Xu, JJ | 1 |
| Dawson, S | 1 |
| Stahl, S | 2 |
| Paul, N | 1 |
| Barber, J | 1 |
| Kenna, JG | 2 |
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 2 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Warner, DJ | 1 |
| Chen, H | 1 |
| Cantin, LD | 1 |
| Walker, CL | 1 |
| Noeske, T | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Chen, M | 1 |
| Suzuki, A | 1 |
| Thakkar, S | 1 |
| Yu, K | 1 |
| Hu, C | 1 |
| Ezhilarasan, D | 1 |
| Devarbhavi, H | 2 |
| Patil, M | 2 |
| Menon, M | 1 |
| Reddy, VV | 1 |
| Singh, R | 1 |
| Joseph, T | 1 |
| Ganga, D | 1 |
| Wonnaparhown, A | 1 |
| Chung, C | 1 |
| Shadix, S | 1 |
| Patel, R | 1 |
| Pandat, S | 1 |
| Chinchilla, D | 1 |
| Lindgren, B | 1 |
| Falk, J | 1 |
| Ohata, C | 1 |
| Nakama, T | 1 |
| Garcia, A | 1 |
| Yi, NJ | 1 |
| Lee, KB | 1 |
| Lee, JM | 1 |
| Choi, YR | 1 |
| Suh, SW | 1 |
| You, T | 1 |
| Lee, KW | 1 |
| Park, JD | 1 |
| Kang, HJ | 1 |
| Kim, JG | 1 |
| Kang, EK | 1 |
| Hong, G | 1 |
| Suh, KS | 1 |
| Schulkes, KJ | 1 |
| Tervaert, JW | 1 |
| Rijken, F | 1 |
| Haas, LE | 1 |
| Ranawaka, RR | 1 |
| Mendis, S | 1 |
| Weerakoon, HS | 1 |
| Sheen, YS | 1 |
| Chu, CY | 1 |
| Wang, SH | 1 |
| Tsai, TF | 1 |
| JELLIFFE, DB | 1 |
| Abidi, MH | 1 |
| Kozlowski, JR | 1 |
| Ibrahim, RB | 1 |
| Peres, E | 1 |
| Tang, H | 1 |
| Min, G | 1 |
| Ge, B | 1 |
| Li, Y | 1 |
| Liu, X | 1 |
| Jiang, S | 1 |
| Revuz, J | 1 |
| Hornac, P | 1 |
| Pattyn, SR | 1 |
| Janssens, L | 1 |
| Bourland, J | 1 |
| Saylan, T | 1 |
| Davies, EM | 1 |
| Grillone, S | 1 |
| Feracci, C | 1 |
| Lal, S | 1 |
| Garg, BR | 1 |
| Tomecki, KJ | 1 |
| Catalano, CJ | 1 |
| Cartel, JL | 1 |
| Millan, J | 1 |
| Guelpa-Lauras, CC | 1 |
| Grosset, JH | 1 |
| Kromann, NP | 1 |
| Vilhelmsen, R | 1 |
| Stahl, D | 1 |
| Dhamija, R | 1 |
| Kumar, D | 1 |
| Khurana, G | 1 |
| Lau, G | 1 |
| Risse, L | 1 |
| Bernard, P | 1 |
| Brosset, A | 1 |
| Enginger, V | 1 |
| Bedane, C | 1 |
| Bonnetblanc, JM | 1 |
| Puri, AS | 1 |
| Gupta, R | 1 |
| Ghoshal, UC | 1 |
| Khan, E | 1 |
| Aggarwal, R | 1 |
| Naik, SR | 1 |
| Barnard, GF | 1 |
| Scharf, MJ | 1 |
| Dagher, RK | 1 |
| Chalasani, P | 1 |
| Baffoe-Bonnie, H | 1 |
| Jurado, RL | 1 |
| Noble, A | 1 |
| MacDonald, A | 1 |
| Prussick, R | 1 |
| Shear, NH | 1 |
| Shuster, J | 1 |
| Keiner, F | 1 |
| Reeve, PA | 1 |
| Ala, J | 1 |
| Hall, JJ | 1 |
| Lons, T | 1 |
| Richardet, JP | 1 |
| Machayekhi, JP | 1 |
| Dalbergue, B | 1 |
| Trinchet, JC | 1 |
| Phillips-Howard, PA | 1 |
| West, LJ | 1 |
| Jayalakshmi, P | 1 |
| Ting, HC | 1 |
| Medina, I | 1 |
| Mills, J | 1 |
| Leoung, G | 1 |
| Hopewell, PC | 1 |
| Lee, B | 1 |
| Modin, G | 1 |
| Benowitz, N | 1 |
| Wofsy, CB | 1 |
| Lawrence, WA | 1 |
| Olsen, HW | 1 |
| Nickles, DJ | 1 |
| Johnson, DA | 1 |
| Cattau, EL | 1 |
| Kuritsky, JN | 1 |
| Zimmerman, HJ | 1 |
4 reviews available for dapsone and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
Dapsone-induced hepatic complications: it's time to think beyond methemoglobinemia.
Topics: Animals; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Dapsone; Dose-Response Relat | 2021 |
[Side effects of treatment with sulfones].
Topics: Adult; Agranulocytosis; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Eruptions; Drug | 1981 |
[Disulone hypersensitivity syndrome].
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Middl | 1994 |
3 trials available for dapsone and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Clofazim | 1984 |
Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Double-Blind Method; Drug Combin | 1992 |
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Chemical and Drug Induced Liver Inj | 1990 |
40 other studies available for dapsone and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Association of human leukocyte antigen-B*13:01 with dapsone-induced liver injury.
Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Dapsone; HL | 2022 |
Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients.
Topics: Adolescent; Adult; Anticonvulsants; Antitubercular Agents; Chemical and Drug Induced Liver Injury; C | 2018 |
Liver injury, rash, and encephalopathy in a 23-year-old Asian man prescribed dapsone.
Topics: Adult; Anti-Infective Agents; Antiviral Agents; Brain Diseases; Chemical and Drug Induced Liver Inju | 2019 |
Granuloma Faciale Treated Successfully with Colchicine.
Topics: Chemical and Drug Induced Liver Injury; Colchicine; Dapsone; Dermatologic Agents; Drug Substitution; | 2019 |
Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: a case report.
Topics: Adult; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Hypersensitivity; Female; Humans | 2014 |
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Topics: Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Dru | 2015 |
Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Glucosep | 2008 |
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Chemical and Drug Induced Liver Injur | 2009 |
French dapsone survey.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; France; Health Care Surveys; | 2002 |
Toxic hepatitis caused by diaminodiphenylsulphone.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Hepatitis; Sulfones; Viral Vaccines | 1951 |
The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.
Topics: Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Exfoliative; Drug Hy | 2006 |
Evaluation of protective effects of Chi-Zhi-Huang decoction on Phase I drug metabolism of liver injured rats by cocktail probe drugs.
Topics: Alanine Transaminase; Animals; Area Under Curve; Aspartate Aminotransferases; Bilirubin; Caffeine; C | 2008 |
Sulphone induced exfoliative dermatitis and hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Exfolia | 1980 |
Dapsone hypersensitivity. The sulfone syndrome revisited.
Topics: Acne Vulgaris; Adolescent; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1981 |
Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
Topics: Adolescent; Adult; Aging; Amides; Chemical and Drug Induced Liver Injury; Dapsone; Drug Therapy, Com | 1983 |
The dapsone syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Humans; Syndr | 1982 |
Dapsone syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Drug Hypersensitivi | 1995 |
A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: dapsone syndrome or rifampicin toxicity?
Topics: Acute Kidney Injury; Aged; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; | 1995 |
Hepatic injury in sulfone syndrome: hepatitis or cholestasis?
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Dapsone; Drug Hypersensiti | 1995 |
Sulfone syndrome in a patient receiving steroids for pemphigus.
Topics: Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Drug Therapy, Combinat | 1994 |
Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1994 |
Drug-induced hepatotoxicity.
Topics: Antimalarials; Chemical and Drug Induced Liver Injury; Dapsone; Drug Combinations; Drug Eruptions; H | 1996 |
Dapsone hypersensitivity syndrome.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Chole | 1996 |
Dapsone and liver failure.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Drug Monitoring; Humans; Liver Failure; Lupu | 1998 |
[Toxic liver lesions caused by alcohol and chemicals].
Topics: Alcoholism; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Contraceptives, Oral, Hor | 1978 |
Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clofazimine; Dapsone; Drug Eruptions; Dru | 1992 |
[Granulomatous hepatitis caused by dapsone].
Topics: Adrenal Cortex Hormones; Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Therapy, Combin | 1992 |
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child, | 1990 |
Dapsone-induced liver necrosis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Seborrheic; Humans; Kidney; Male | 1990 |
Dapsone hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis Herpetiformis; Female; Humans | 1987 |
Liver involvement in the sulfone syndrome.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Liver | 1986 |